Navigation Links
Takeda to Acquire Inviragen, Inc.
Date:5/7/2013

eted Phase 1 clinical testing. Inviragen has also developed a recombinant vaccine candidate to protect against chikungunya, currently in preclinical development.

"The acquisition of Inviragen supports Takeda's overall research and development programs, long-term growth strategy and commitment to improve health through innovation and new technology," said Tadataka Yamada , M.D., Takeda's chief medical and scientific officer and member of the Takeda board of directors. "Coming less than a year after the acquisition of LigoCyte with the world's leading norovirus vaccine candidate, this illustrates Takeda's commitment to its global vaccine business and global public health."

Dengue is the most important mosquito-borne viral illness in the world, and is one of four World Health Organization (WHO) future vaccine priorities. It is estimated that about 400 million people worldwide are infected by the dengue virus each year, of which nearly 100 million develop clinical illness. Approximately 500,000 people are hospitalized and 20,000, mostly children, die from severe complications such as hemorrhagic fever. Currently there are only symptomatic treatments available for dengue and dengue hemorrhagic fever, and the only means of prevention is through mosquito control. The number of reported symptomatic dengue infections has increased 30-fold in the past 50 years, and the global footprint of dengue is expanding. HFMD epidemics occur annually throughout the Asia Pacific region, with millions of cases reported yearly since 2010. Chikungunya, which is a mosquito-transmitted virus, has produced epidemics in Africa, India, Asia and Europe. There are no specific treatments or cures for dengue, HFMD or chikungunya. Takeda will work with governments and international organizations to ensure that these vaccines reach
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda Responds to Verdict in Diabetes Drug Case
2. Takeda Launches New Subsidiary in Ecuador
3. Takeda lanza nueva subsidiaria en Ecuador
4. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
5. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
6. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
7. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
9. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
10. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
11. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... -- IRIDEX Corporation (Nasdaq: IRIX ) today reported financial ... 2015.  , Revenues were $11.8 million in the ... up 11% from $10.6 million in the 2013 fourth quarter. ... 12% from $38.3 million in 2013. , Gross margin ... in the fourth quarter of the prior year. , ...
(Date:3/5/2015)... 2015  As the pharmaceutical industry works to ... Compliance professionals are placing a significant emphasis on ... today by LRN, the leader in Ethics & ... of respondents expressed that clarity on company values ... E&C training programs (57%), trumping understanding of the ...
(Date:3/5/2015)... FALLS, N.J. , March 5, 2015 CANTEL ... results for its second quarter ended January 31, 2015 on ... conference call to discuss the results at 11:00 AM ET. ... (877) 407-8033 approximately 5 to 10 minutes before the beginning ... digital replay of the call will be available from Thursday, ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
(Date:3/6/2015)... Follow us on LinkedIn ... forms of cancer and is the leading cause of ... through various techniques and tools, including mammography, MRI and ... standard technique in breast cancer screening, driven by a ... the procedure, required expertise to carry out the procedure ...
(Date:3/6/2015)... 2015 Ticket Down is a reputable source ... exchange has extended their customer appreciation discount code ED-SHEERAN-2015 for ... Yorkshire England and he began his career in the music ... couple of years Ed Sheeran has become a household name. ... on stage he is having the time of his life ...
(Date:3/6/2015)... GA (PRWEB) March 06, 2015 Further ... leader , Medical Doctor Associates announced today that the ... Award after winning the Best of Staffing Talent Award ... CareerBuilder, Inavero’s Best of Staffing Talent Diamond winners are ... ratings given to them by the individuals they have ...
(Date:3/6/2015)... 06, 2015 Since Medicare began paying ... there has been an overwhelming demand from providers for ... compliant CCM program. The Centers for Medicare & ... , PYA’s updated white paper—“ Providing and Billing ... into a detailed, yet practical “how to” manual for ...
(Date:3/6/2015)... 2015 Magellan Rx Management’s 2014 Medical ... for key trends and statistics on one of the ... from Magellan Rx Management will discuss key findings from ... Hidden Specialty Drug Spend,” a complimentary March 19 webinar, ... Specialty drug spend makes up more than a quarter ...
Breaking Medicine News(10 mins):Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... highlights need for complete, unbiased information on Medicare choices. ... ... 2008 - Medicare beneficiaries trying to sort through their healthcare ... them against overly aggressive marketing tactics by some insurance companies ...
... the resulting acne scars which last long after ... distress. Now, a new study recently published ... issue), the peer-reviewed professional journal of the American ... a novel laser device combining CO2 ablation with ...
... States to End the Tobacco Settlement Spending Spree and Direct ... WASHINGTON, Nov. 19 This Sunday, November 23, ... of the largest civil settlement in United States history. The ... 46 states and the major tobacco companies that reimbursed the ...
... Project Report Makes Recommendations for System in Critical Need of ... 17 Weaknesses in food safety policy, organization and communications ... according to a report released today by the Produce Safety ... Georgetown University . , ...
... 18 Women who undergo weight-loss surgery, known as bariatric surgery, ... lower risk for pregnancy-related diabetes and high blood pressure -- ... -- than pregnant women who are obese, according to new ... are published in the November 19 issue of JAMA. ...
... Strange Appointed to CEO position and Will Join Board, Effective ... MELVILLE, N.Y., Nov. 18 /PRNewswire-FirstCall/ -- Gentiva ... provider of comprehensive home health services, announced today that its ... Effective January 1, 2009, Tony Strange will become the Company,s ...
Cached Medicine News:Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 2Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 3Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 4Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 2Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 3Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 4Health News:November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History 2Health News:November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History 3Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 2Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 3Health News:Some Pregnancy-Related Complications Minimized for Women Who Have Had Weight-Loss Surgery 2Health News:Some Pregnancy-Related Complications Minimized for Women Who Have Had Weight-Loss Surgery 3Health News:Gentiva Health Services Confirms Management Succession 2Health News:Gentiva Health Services Confirms Management Succession 3Health News:Gentiva Health Services Confirms Management Succession 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: